Tadalis SX
Tadalis SX Price range: $ 56,00 through $ 219,00
Back to products
Tadalista Professional
Tadalista Professional Price range: $ 55,00 through $ 684,00

Tadalista

Price range: $ 42,00 through $ 414,00

Tadalista is a highly effective medication specifically designed to address symptoms of erectile dysfunction in men. This formula utilizes Tadalafil to improve blood flow to specific areas of the body, enabling a reliable response to sexual stimulation. It is widely recognized for its extended duration of action, offering a window of effectiveness that lasts for up to 36 hours. By supporting the ability to achieve and sustain a firm erection, it helps restore confidence in intimate situations. Tadalista provides a dependable solution for those seeking to enhance their sexual health and enjoy more spontaneous experiences.

Active substance: Tadalafil
SKU: Tadalista Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Tadalista contains tadalafil, an active pharmaceutical ingredient belonging to the class of phosphodiesterase type 5 (PDE5) inhibitors. In clinical therapeutics, PDE5 inhibitors are primarily utilized to manage erectile dysfunction (ED) and lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH) by facilitating smooth muscle relaxation and targeted vascular dilation.

In the United States, tadalafil-containing preparations are prescription-only medications dispensed in accordance with applicable federal and state regulations. Patients evaluating therapeutic options for erectile dysfunction or lower urinary tract symptoms should undergo formal clinical assessment before initiating therapy to ensure appropriateness and safety.

Attribute Specification
Drug Name Tadalista
Active Ingredient Tadalafil
Therapeutic Class Phosphodiesterase Type 5 (PDE5) Inhibitor
Dosage Form Oral tablet
Route of Administration Oral
Primary Purpose Management of erectile dysfunction and BPH symptoms
Prescription Status Dispensed in accordance with applicable federal and state regulations

Clinical Overview and Pharmacologic Profile

Main uses

Tadalista is indicated for the treatment of erectile dysfunction, a condition characterized by the persistent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. Additionally, tadalafil is utilized to treat the signs and symptoms of benign prostatic hyperplasia, such as urinary frequency, urgency, and hesitancy. On one hand, the medication provides targeted symptom relief by improving regional vascular flow; on the other hand, it does not cure underlying vascular, neurological, or endocrine etiologies causing these conditions. When evaluated in clinical practice, treatment outcomes depend significantly on overall cardiovascular health, baseline neural function, and appropriate patient compliance with prescribed dosing regimens.

How the drug works

The therapeutic mechanism of tadalafil centers on the selective inhibition of the cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 enzyme. During sexual stimulation, local endothelial release of nitric oxide (NO) stimulates the enzyme guanylate cyclase, leading to increased synthesis of cGMP in the vascular smooth muscle of the corpus cavernosum. Elevated cGMP levels induce smooth muscle relaxation, arterial engorgement, and subsequent erection. By selectively blocking PDE5, tadalafil prevents the enzymatic degradation of cGMP, thereby prolonging and strengthening the physiological erectile response. It is critical to note that the medication requires intact sexual stimulation to initiate endogenous nitric oxide release.

What happens in the body

Following oral administration, tadalafil is absorbed rapidly, reaching peak plasma concentrations ($C_{max}$) within a median time of 2 hours (range: 0.5 to 6 hours). Unlike certain other PDE5 inhibitors, the rate and extent of tadalafil absorption are not meaningfully affected by food intake. The mean terminal half-life ($t_{1/2}$) of tadalafil in healthy subjects is approximately 17.5 hours, which translates to an extended duration of therapeutic effect lasting up to 36 hours. Tadalafil is extensively bound to plasma proteins (~94%) and undergoes primary hepatic metabolism via the cytochrome P450 3A4 (CYP3A4) pathway. Elimination occurs predominantly as inactive metabolites, with approximately 61% excreted in feces and 36% in urine.

Dosing schedule

Dosing schedules for tadalafil are determined individually by a licensed prescriber based on indication, tolerability, and clinical objectives. For on-demand treatment of erectile dysfunction, a initial standard dose of 10 mg is frequently evaluated prior to anticipated sexual activity, with potential adjustments to 20 mg or reduced to 5 mg based on individual efficacy and side effect profiles. Alternatively, a low-dose daily regimen (2.5 mg to 5 mg once daily at approximately the same time each day) may be recommended for patients desiring spontaneous activity or those co-managing BPH symptoms. Dose reductions are mandatory in patients with significant renal impairment (creatinine clearance under 30 mL/min) or hepatic insufficiency.

Safety, Interactions, and Practical Considerations

Adverse reactions

While tadalafil is generally well tolerated, adverse effects can occur due to systemic PDE5 inhibition and peripheral vasodilation. The most commonly reported side effects include headache, dyspepsia (indigestion), back pain, myalgia (muscle aches), nasal congestion, and facial flushing. Back pain and myalgia typically manifest 12 to 24 hours post-dose and generally resolve spontaneously within 48 hours. Less frequent but severe adverse events include sudden decrease or loss of hearing, non-arteritic anterior ischemic optic neuropathy (NAION), and hypersensitivity reactions. Patients experiencing persistent or severe discomfort should consult their prescribing physician for clinical evaluation.

Compatibility with other medicines

Tadalafil exhibits significant potential for pharmacokinetic and pharmacodynamic interactions. Concomitant administration of organic nitrates in any form (including nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, or recreational inhaled nitrites known as “poppers”) is strictly contraindicated due to the risk of severe, life-threatening hypotension. Co-administration with alpha-adrenergic blockers (such as tamsulosin or doxazosin) or antihypertensive agents requires careful clinical titration to minimize orthostatic hypotension. Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) increases systemic tadalafil exposure, whereas strong CYP3A4 inducers (e.g., rifampin, carbamazepine) significantly reduce therapeutic concentrations.

Important precautions

Before starting treatment, a thorough cardiovascular assessment is required, as sexual activity carries an inherent cardiac risk. Tadalafil should be used with extreme caution in patients with recent myocardial infarction (within 90 days), unstable angina, severe heart failure, uncontrolled cardiac arrhythmias, severe hypotension, or recent stroke (within 6 months). Clinical protocols observed in healthcare centers such as those in Chicago emphasize comprehensive baseline screening before initiating PDE5 inhibitor therapy. Patients with anatomical penile deformations (such as Peyronie’s disease) or conditions predisposing them to priapism (such as sickle cell anemia, multiple myeloma, or leukemia) require close medical supervision.

What to avoid while taking it

Patients taking tadalafil should exercise caution regarding substance consumption. Moderate alcohol consumption may be permissible, but excessive alcohol intake (e.g., more than 5 units) combined with tadalafil increases the risk of orthostatic hypotension, dizziness, headache, and elevated heart rate. Grapefruit juice can inhibit CYP3A4 metabolism, potentially increasing blood levels of tadalafil and elevating the incidence of side effects. Avoid taking other PDE5 inhibitors or alternative erectile dysfunction therapies simultaneously unless explicitly advised by a qualified prescriber.

Red flags

Immediate medical attention is necessary if specific severe adverse events arise during treatment. Patients must seek emergency care if they experience an erection lasting longer than 4 hours (priapism), as delayed intervention can result in permanent erectile tissue damage. Sudden visual impairment in one or both eyes, potential symptoms of NAION, warrants immediate drug discontinuation and ophthalmologic evaluation. Similarly, sudden loss or reduction of hearing, often accompanied by tinnitus or dizziness, requires prompt emergency evaluation.

If you skip a dose

For patients prescribed a once-daily dosing regimen, a missed dose should be taken as soon as remembered on that day. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. Patients must never take a double dose or take extra tablets to compensate for a missed administration. For on-demand dosing regimens, missed dose protocols are not applicable, as the medication is ingested only prior to anticipated sexual activity.

Storage and expiration

Tadalista tablets should be stored at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), with short excursions permitted between 59°F and 86°F (15°C to 30°C). Keep the medication in its original blister packaging to protect it from excessive moisture, heat, and direct light. Ensure the tablets are stored securely out of reach of children and pets. Do not use the medication beyond the expiration date printed on the packaging, and dispose of unused product according to local pharmaceutical waste guidelines.

Common questions

Why does tadalafil last longer than other PDE5 inhibitors?

Tadalafil possesses a distinct molecular structure that yields a terminal elimination half-life of approximately 17.5 hours, compared to 3 to 5 hours for agents like sildenafil. This extended half-life maintains therapeutic plasma concentrations over a 36-hour window, allowing for sustained efficacy without requiring frequent redosing.

Can tadalafil be taken daily instead of on-demand?

Yes, daily administration at lower doses (2.5 mg or 5 mg) is an established therapeutic strategy. This option provides continuous plasma levels, removing the need to plan medication timing around sexual activity, and is also approved for treating BPH symptoms.

What causes muscle pain and back pain after taking tadalafil?

Back pain and myalgia are recognized class-related side effects thought to result from mild inhibition of PDE11 enzymes present in skeletal muscle tissue. These symptoms are typically mild to moderate, appear 12 to 24 hours after administration, and resolve without long-term sequelae within 48 hours.

Is it necessary to take tadalafil on an empty stomach?

No, clinical pharmacokinetic data show that food intake does not meaningfully alter the rate or extent of tadalafil absorption. Patients may take the tablet with or without meals according to personal preference.

How does renal impairment affect tadalafil dosing?

Because tadalafil metabolites are partially excreted by the kidneys, impaired renal function slows clearance. Patients with moderate renal impairment ($CrCl$ 30 to 50 mL/min) or severe impairment ($CrCl < 30$ mL/min) require lower starting doses and extended dosing intervals to prevent systemic drug accumulation.

This content is informational and does not replace a consultation with your doctor or pharmacist. In accordance with FDA requirements.

Additional information
Dosage

10mg

,

20mg

,

40mg

Package

20 pills

,

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία